Analyst Corner 6 minutesRegister for Free AccessAnalyst Corner—Inside the GLP-1 Boom in the US, with Madhav Pitaliya Madhav Pitaliya, Analyst September 1, 2024 What's InsideWelcome to Analyst Corner! Every Sunday, a member of the Coresight Research team discusses upcoming or recent research and their thoughts on interesting topics in their area of expertise. This week, Madhav Pitaliya, Analyst at Coresight Research, discusses the state of the GLP-1 drug market in the US. Understand key data on obesity rates and recent sales results for weight-loss drugs in this free research report. We also highlight our key research from the past week and reports to look out for in the coming week, so you don’t miss out. Other relevant research: Decoding the GLP-1 Trend: How Is the Ozempic Economy Impacting CPG Retail? What the Ozempic Economy Means for US Retail Data Dive: The Global Obesity Economy—Shaped by the Spending of 1 Billion Consumers Read previous Analyst Corner reports, including last week’s report, which discusses headline data about China’s declining population. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: The US Retail Media Market: Understanding the Ad Buyer’s Perspective in CPGRetailTech: Loss Prevention—Understanding the Big Picture To Prevent, Mitigate and Recover “Shrink”ing ProfitsWeekly US and UK Store Openings and Closures Tracker 2024, Week 3: Greggs To Open 140 Stores in the UKMacy’s Announces 150 Store Closures—A Turnaround Effort To Drive Performance
